CatalystTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Catalyst Company Product/Project Catalyst Title
Companies Markets All
Disclosure

Catalysts

Expected
Date Range
Lead
Company
Catalyst* Product/Project Market
Now - 07/25/16 Subscribers Only Regulatory - PDUFA/Approval Decision (US) Subscribers Only Diabetes Mellitus, Type II
07/27/16 Subscribers Only Trial Data - Top-Line Results Subscribers Only Alzheimer's Disease - Imaging
07/27/16 Subscribers Only Trial Data - Top-Line Results Subscribers Only Alzheimer's Disease (AD)
Now - 07/29/16 Subscribers Only Regulatory - PDUFA/Approval Decision (US) Subscribers Only Diabetes Mellitus, Type II
Now - 07/29/16 Subscribers Only Regulatory - PDUFA/Approval Decision (US) Subscribers Only Neuromuscular Spasm and Spasticity
07/29/16 Subscribers Only Regulatory - PDUFA/Approval Decision (US) Subscribers Only Primary Immunodeficiencies
Now - 07/30/16 Subscribers Only Regulatory - PMA Supplemental Approval Decision Subscribers Only Ventricular Tachycardia or Fibrillation
Now - 07/31/16 Subscribers Only Trial Data - Top-Line Results Subscribers Only Neurology - Other
*Only Large Impact Catalysts are displayed.